v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (49,692) $ 192,323
Adjustments to reconcile net income to cash flows from operating activities:    
Depreciation and amortization 76,865 23,319
Amortization of inventory step-up 72,397 0
Share-based compensation expense 94,216 72,441
Change in fair value of contingent consideration 26,982 0
Deferred income taxes 329 30,494
Loss on debt extinguishment 538 0
Other non-cash charges 8,091 4,396
Changes in assets and liabilities:    
Receivables (74,675) 30,134
Contract assets 0 4,273
Inventory 9,860 (9,198)
Prepaid expenses and other assets (33,610) (2,984)
Right-of-use assets 6,660 5,628
Accounts payable and accrued expenses (116,444) 27,864
Accrued sales discounts, allowances and reserves 53,207 (19,709)
Contract liabilities 0 (1,249)
Operating lease liabilities (8,550) (7,733)
Other long-term liabilities 6,743 686
Cash flows provided by operating activities 72,917 350,685
CASH FLOWS FROM INVESTING ACTIVITIES:    
Additions of property, plant and equipment (15,638) (40,440)
Proceeds from the sale of property, plant and equipment 14 34
Proceeds from the sale of the Athlone facility 0 1,708
Business combination, net of cash acquired (2,085,073) 0
Purchases of investments (65,406) (308,534)
Sales and maturities of investments 106,682 320,383
Cash flows used in investing activities (2,059,421) (26,849)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the issuance of ordinary shares under share-based compensation arrangements 55,622 32,233
Payment for the repurchase of ordinary shares (27,696) 0
Employee taxes paid related to net share settlement of equity awards (25,211) (30,766)
Proceeds from the issuance of debt, net 1,557,097 0
Payments of deferred financing costs (2,980) 0
Principal payments of long-term debt (58,790) 0
Cash flows provided by financing activities 1,498,042 1,467
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (488,462) 325,303
CASH, CASH EQUIVALENTS AND RESTRICTED CASH-Beginning of period 1,119,776 291,146
CASH, CASH EQUIVALENTS AND RESTRICTED CASH-End of period 631,314 616,449
SUPPLEMENTAL CASH FLOW DISCLOSURE:    
Cash paid for taxes 34,894 3,108
Non-cash investing and financing activities:    
Purchased capital expenditures included in accounts payable and accrued expenses 3,145 5,263
Unpaid deferred financing costs to third-parties 132 0
Contingent consideration issued in business combination $ 107,713 $ 0